Error: Could not add to watchlist. X
+ Watchlist

Medivir AB

MVIRILB:SS
Stockholm
Pending Listing
MVIRILB:SS is pending listing
SEK
Volume
0
Before it's here, it's on the Bloomberg Terminal.
Learn More
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (SEK) (TTM)
-
Market Cap (SEK)
-
Shares Outstanding
-
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
+0.43%
% Price Change
+0.39%

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Medivir AB is a medical research company. The Company develops new drugs and pharmaceutical compounds based on proteases and polymerases as target enzymes. Medivir focuses on infectious and immunological diseases including projects against HIV, jaundice, shingles, multiple sclerosis, and rheumatoid arthritis. The Company is located in Huddinge, Sweden and Cambridge, United Kingdom.
Address
Lunastigen 7
Huddinge, 141 44
Sweden
Phone
46-8-546-831-00
Show More